Greenwall Faculty Scholar Alums have been active in the news, raising their voices and perspectives around some of the potential policy changes and directives from the new administration that intersect with bioethics issues. Read on below.
Govind Persad, JD, PhD, on KUSA News (Denver):
President Trump’s Executive Order Targeting Transgender People Could be Challenged
January 21, 2025
“We know that the president cannot just issue an executive order saying they are covered or not covered in Medicaid, that’s not how Medicaid and Medicare work[.]”
Aaron Kesselheim, MD, JD, in The New York Times:
Kennedy Wants to Overhaul the F.D.A. Here’s How Experts Would Change It.
December 22, 2024
“The F.D.A. isn’t a perfect institution … [but] it’s the most important public health agency that we have, and the role that it fills in our health care system is essential.”
Aaron Kesselheim, MD, JD, co-authored a piece in Health Affairs Forefront:
Will The New Administration’s FDA Be A Threat Or An Opportunity For The Public’s Health?
December 13, 2024
“As various reform ideas are proposed, the organized medical and scientific community will need to work with the new leadership to promote positive change–and oppose initiatives that undermine the agency, its workforce, and its mission.”
Ronit Stahl, PhD, in The Associated Press:
US Military Takes Pride in Religious Diversity. Would Things Change if Pete Hegseth Takes Charge?
December 4, 2024
Today’s military “is one of the most diverse institutions in American society, racially, ethnically and especially religiously[.]”
Holly Fernandez Lynch, JD, in The New York Times:
Kennedy Doesn’t Like Ozempic. Here’s What He Can Do About It.
November 22, 2024
When it comes to issues that might drive the F.D.A. to withdraw approval, “none of those apply to the GLP-1’s,” [Prof.] Lynch said, referring to the new obesity drugs. “Full stop.”
Aaron Kesselheim, MD, JD, in NBC News:
Trump’s Tariffs Could Raise the Cost of Generic Drugs in the U.S.
November 22, 2024
“The price and the cost of production, which includes shipping a product, and the supply chain are closely linked,” [Dr.] Kesselheim said. “When there are disruptions to the supply chain, like tariffs, that can lead to shortages, and it’ll raise prices.”
Jonathan Oberlander, PhD, on WFAE (Charlotte):
What Could Trump’s Election Mean for Health Care in North Carolina?
November 15, 2024
“I think there’s a very good chance that Medicaid is going to be targeted again for savings and I think there will be a budgetary battle over Medicaid. It won’t be easy though.”
Holly Fernandez Lynch, JD, in Bloomberg News:
RFK Jr. Will Not Be Good for America’s Health
November 7, 2024
“The amount of damage that could be done could be astronomical at a time when there’s so much mistrust about science, about vaccines, and about FDA.’”